GlassScriptPhysician profile
Sheila Hart
NPI 1265862320
$423.44
in general payments reported to CMS, 2019-2025
10 companies · $61.59 in 2025
The $61.59 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.58 · 2022: $33.74 · 2023: $133 · 2024: $155 · 2025: $61.59.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $349.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $169.52 | 2021-2024 | |
| Braeburn INC. | $87.67 | 2024-2025 | Brixadi |
| Ironshore Pharmaceuticals INC. | $39.19 | 2023 | Jornay Pm |
| Indivior INC. | $29.15 | 2024 | Sublocade |
| Harmony Biosciences LLC | $19.81 | 2023 | Wakix |
| Teva Pharmaceuticals USA, INC. | $18.43 | 2023 | Uzedy |
| Lundbeck LLC | $16.88 | 2022 | |
| Sunovion Pharmaceuticals INC. | $16.86 | 2022 | |
| Eisai INC. | $13.76 | 2021 | |
| Lilly USA, LLC | $12.17 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sheila Hart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.